TEVA|Teva Pharmaceutical Industries Ltd|株価:32.830|変動率:-0.24

詳細情報 Teva Pharmaceutical Industries Ltd 企業名

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.

Teva Pharmaceutical Industries Ltdの企業情報



企業コードTEVA

会社名Teva Pharmaceutical Industries Ltd

上場日Feb 06, 2087

最高経営責任者「CEO」Francis (Richard D)

従業員数33892

証券種類Depository Receipt

決算期末Feb 06

本社所在地124 Dvora Hanevi'a St.

都市TEL AVIV-YAFO

証券取引所NASDAQ OMX NASDAQ Basic NYSE

国Israel

郵便番号6944020

電話番号97239148213

ウェブサイトhttps://www.tevapharm.com/

企業コードTEVA

上場日Feb 06, 2087

最高経営責任者「CEO」Francis (Richard D)

Teva Pharmaceutical Industries Ltdの経営陣



会社名

会社名/ポジション

ポジション

株式保有

変動額

Prof. Varda Shalev

Independent Director

22.50K

+9632.00%

Ms. Christine (Chris) Fox

Executive Vice President - U.S. Commercial

14.28K

+14280.00%

Mr. Amir Elstein

Independent Director

--

Mr. Mark Sabag

Executive Vice President - International Markets Commercial

--

Dr. Sol J. Barer, Ph.D.

Independent Chairman of the Board

--

Ms. Rosemary A. (Rose) Crane

Independent Director

--

Mr. Gerald M. (Jerry) Lieberman

Independent Director

--

Mr. Richard Daniell

Executive Vice President - European Commercial

--

Mr. Roberto A. Mignone

Independent Director

--

Dr. Perry D. Nisen, M.D., Ph.D.

Independent Director

--

詳細を見る

会社名

会社名/ポジション

ポジション

株式保有

変動額

Prof. Varda Shalev

Independent Director

22.50K

+9632.00%

Ms. Christine (Chris) Fox

Executive Vice President - U.S. Commercial

14.28K

+14280.00%

Mr. Amir Elstein

Independent Director

--

Mr. Mark Sabag

Executive Vice President - International Markets Commercial

--

Dr. Sol J. Barer, Ph.D.

Independent Chairman of the Board

--

Ms. Rosemary A. (Rose) Crane

Independent Director

--

収益内訳

通貨: USD更新時刻: Tue, Jan 6

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

事業別USD

会社名

収益

比率

Generic products

2.58B

57.54%

AUSTEDO

609.00M

13.59%

Anda

392.00M

8.75%

Other

274.00M

6.12%

AJOVY

169.00M

3.77%

他の

458.00M

10.22%

地域別USD

会社名

収益

比率

United States

2.48B

55.40%

Europe

1.24B

27.57%

International Markets

558.00M

12.46%

Other

205.00M

4.58%

事業別

地域別

事業別USD

会社名

収益

比率

Generic products

2.58B

57.54%

AUSTEDO

609.00M

13.59%

Anda

392.00M

8.75%

Other

274.00M

6.12%

AJOVY

169.00M

3.77%

他の

458.00M

10.22%

株主

更新時刻: Sun, Jan 11

株主統計

種類

株主統計

比率

Phoenix Investment and Finances Ltd

3.60%

Menora Mivtachim Insurance Ltd.

3.39%

Harel Insurance Investments and Financial Services Ltd

3.29%

Migdal Insurance and Financial Holdings Ltd

3.26%

BlackRock Institutional Trust Company, N.A.

3.04%

他の

83.42%

株主統計

比率

Phoenix Investment and Finances Ltd

3.60%

Menora Mivtachim Insurance Ltd.

3.39%

Harel Insurance Investments and Financial Services Ltd

3.29%

Migdal Insurance and Financial Holdings Ltd

3.26%

BlackRock Institutional Trust Company, N.A.

3.04%

他の

83.42%

種類

株主統計

比率

Investment Advisor

22.43%

Investment Advisor/Hedge Fund

12.50%

Hedge Fund

10.44%

Insurance Company

6.24%

Research Firm

2.31%

Pension Fund

1.69%

Family Office

1.47%

Bank and Trust

0.90%

Sovereign Wealth Fund

0.24%

他の

41.78%

機関投資家保有株



更新時刻: Thu, Jan 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q4

1124

659.56M

57.49%

-135.68M

2025Q3

1124

742.23M

64.70%

-84.92M

2025Q2

1100

749.18M

65.31%

-13.97M

2025Q1

1130

727.69M

63.46%

-282.41K

2024Q4

1087

683.52M

59.66%

-22.86M

2024Q3

1029

663.95M

58.60%

-6.13M

2024Q2

1002

631.05M

55.72%

-26.20M

2024Q1

950

595.83M

53.15%

-34.73M

2023Q4

932

601.27M

53.63%

+7.51M

2023Q3

929

573.53M

51.16%

-84.22M

詳細を見る

株主動向



会社名

保有株式数

比率

変動額

変動率

日付

Phoenix Investment and Finances Ltd

41.30M

3.6%

+3.53M

+9.36%

Sep 30, 2025

Menora Mivtachim Insurance Ltd.

38.92M

3.39%

-18.47M

-32.19%

Sep 30, 2025

Harel Insurance Investments and Financial Services Ltd

37.70M

3.29%

+4.31M

+12.90%

Sep 30, 2025

Migdal Insurance and Financial Holdings Ltd

32.58M

2.84%

+3.90M

+13.58%

Sep 30, 2025

BlackRock Institutional Trust Company, N.A.

34.92M

3.04%

+1.03M

+3.04%

Sep 30, 2025

Clal Insurance Enterprises Holdings Ltd.

31.49M

2.74%

-876.00K

-2.71%

Sep 30, 2025

Lingotto Investment Management LLP

28.59M

2.49%

+431.87K

+1.53%

Sep 30, 2025

Rubric Capital Management LP

24.65M

2.15%

-1.35M

-5.19%

Sep 30, 2025

PointState Capital LP

20.71M

1.81%

--

Sep 30, 2025

Fidelity Management & Research Company LLC

20.19M

1.76%

-30.45M

-60.13%

Sep 30, 2025

詳細を見る

配当金



過去5年間の配当金総支払額は 0.00 米ドルである。

日付

配当金

権利確定日

支払日

配当落ち日

データなし

株式分割



日付

配当落ち日

種類

比率

データなし

日付

配当落ち日

種類

比率

データなし

Teva Pharmaceutical Industries Ltd

詳細情報 Teva Pharmaceutical Industries Ltd 企業名

Teva Pharmaceutical Industries Ltdの企業情報

Teva Pharmaceutical Industries Ltdの経営陣

収益内訳

株主

機関投資家保有株

株主動向

関連ETF

配当金

株式分割